Emd Serono Drug Patent Portfolio
Emd Serono owns 9 orange book drugs protected by 13 US patents with Luveris having the least patent protection, holding only 1 patent. And Egrifta with maximum patent protection, holding 6 patents. Given below is the list of Emd Serono's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7741268 | Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant | 02 Apr, 2024 | Expired |
| US7316997 | GH secretagogues and uses thereof | 14 Aug, 2023 | Expired |
| US8314066 | GH secretagogues and uses thereof | 14 Aug, 2023 | Expired |
| US8435945 | GH secretagogues and uses thereof | 14 Aug, 2023 | Expired |
| US6706681 | HCG liquid formulations | 16 Mar, 2021 | Expired |
| US7144577 | Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy | 14 Jul, 2020 | Expired |
| US7563763 | FSH and FSH variant formulations, products and methods | 23 Aug, 2019 | Expired |
| US7446090 | FSH formulation | 23 Aug, 2019 | Expired |
| US5898030 | hGH containing pharmaceutical compositions | 27 Apr, 2016 | Expired |
| US5767067 | Follicle stimulating hormone and pharmaceutical compositions containing same | 16 Jun, 2015 | Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof | 16 Jun, 2015 | Expired |
| US5861379 | Chimeric fatty body-pro-GRF analogs with increased biological potency | 26 May, 2015 | Expired |
| US6020311 | GRF analogs with increased biological potency | 26 May, 2015 | Expired |
Latest Legal Activities on Emd Serono's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Emd Serono.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Maintenance Fee Reminder Mailed
Critical
| 08 Jul, 2024 | US8314066 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Dec, 2021 | US7741268 |
|
Expire Patent
Critical
| 23 Aug, 2021 | US7563763 |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Mar, 2021 | US7563763 |
|
Expire Patent
Critical
| 07 Dec, 2020 | US7446090 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Oct, 2020 | US8435945 |
|
Maintenance Fee Reminder Mailed
Critical
| 22 Jun, 2020 | US7446090 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 May, 2020 | US8314066 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Jun, 2019 | US7316997 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 May, 2018 | US7144577 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Dec, 2017 | US7741268 |
| Sequence Moved to Public Database | 09 May, 2013 | US8435945 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 May, 2013 | US8435945 |
|
Recordation of Patent Grant Mailed
Critical
| 07 May, 2013 | US8435945 |
|
Email Notification
Critical
| 18 Apr, 2013 | US8435945 |
Emd Serono's Drug Patent Litigations
Emd Serono's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jul 06, 2000, against patent number US6706681. The petitioner , challenged the validity of this patent, with SAMARITANI et al as the respondent. Click below to track the latest information on how companies are challenging Emd Serono's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6706681 | July, 2000 |
Decision
(23 Jan, 2002)
| SAMARITANI et al | |
Emd Serono's Family Patents
Emd Serono Drug List
Given below is the complete list of Emd Serono's drugs and the patents protecting them.
1. Egrifta
Egrifta is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7316997 | GH secretagogues and uses thereof |
14 Aug, 2023
(1 year, 3 months ago)
| Expired |
| US8314066 | GH secretagogues and uses thereof |
14 Aug, 2023
(1 year, 3 months ago)
| Expired |
| US8435945 | GH secretagogues and uses thereof |
14 Aug, 2023
(1 year, 3 months ago)
| Expired |
| US7144577 | Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy |
14 Jul, 2020
(4 years ago)
| Expired |
| US5861379 | Chimeric fatty body-pro-GRF analogs with increased biological potency |
26 May, 2015
(9 years ago)
| Expired |
| US6020311 | GRF analogs with increased biological potency |
26 May, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Egrifta's drug page
2. Gonal-f
Gonal-f is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7563763 | FSH and FSH variant formulations, products and methods |
23 Aug, 2019
(5 years ago)
| Expired |
| US5767067 | Follicle stimulating hormone and pharmaceutical compositions containing same |
16 Jun, 2015
(9 years ago)
| Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gonal-f's drug page
3. Gonal-f Rff
Gonal-f Rff is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5767067 | Follicle stimulating hormone and pharmaceutical compositions containing same |
16 Jun, 2015
(9 years ago)
| Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gonal-f Rff's drug page
4. Gonal-f Rff Pen
Gonal-f Rff Pen is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7741268 | Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant |
02 Apr, 2024
(7 months ago)
| Expired |
| US7446090 | FSH formulation |
23 Aug, 2019
(5 years ago)
| Expired |
| US5767067 | Follicle stimulating hormone and pharmaceutical compositions containing same |
16 Jun, 2015
(9 years ago)
| Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gonal-f Rff Pen's drug page
5. Luveris
Luveris is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luveris's drug page
Explore Our Curated Drug Screens
6. Ovidrel
Ovidrel is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6706681 | HCG liquid formulations |
16 Mar, 2021
(3 years ago)
| Expired |
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
16 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ovidrel's drug page
7. Saizen
Saizen is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5898030 | hGH containing pharmaceutical compositions |
27 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Saizen's drug page
8. Serostim
Serostim is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5898030 | hGH containing pharmaceutical compositions |
27 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Serostim's drug page
9. Zorbtive
Zorbtive is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5898030 | hGH containing pharmaceutical compositions |
27 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zorbtive's drug page